Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918650 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
Our studies show that APO866-induced NAD+ depletion enhances radiation responses in tumor cell survival in prostate cancer. However, the in vitro data do not reveal a solid cellular mechanism to exploit further clinical development at this moment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shuraila F. Zerp, Conchita Vens, Ben Floot, Marcel Verheij, Baukelien van Triest,